a pre-AIDS syndrome remains uncertain but recognition of this better prognostic group is clearly important.
We report a patient who suffered from myotonic dystrophy and parathyroid hyperplasia, an association which, to our knowledge, has not previously been described.
Case report A 52-year-old woman (RNSH 681329) with a 23 year history of muscular weakness was admitted because of drowsiness and dehydration. Muscular weakness had been present since age 29. At the age of 33 years, myotonic dystrophy was diagnosed on the basis ofclinical findings, electromyography and muscle biopsy. Subsequent family studies revealed myotonia in one sister (who is normocalcaemic), this sister's daughter and in three of the patients' four children.
Approximately 8 months before admission, the patient developed nausea, vomiting and increasing weakness. Examination showed muscle weakness, delayed relaxation of handgrip and slight frontal balding. Serum calcium was 4.05 mmoMl (16.2 mg/dl), inorganic phosphate 0.35 mmol/l (1.05 mg/dl), alkaline phosphatase 245 U/I (normal 20-95), and immunoreactive parathyroid hormone (PTH)1 5.07 ng/ml (normal less than 0.4 ng/ml). Serum osteocalcin (bone Gla protein) was 18.2 ng/ml (normal 2.1-8.1). Nephrogenous cAMP was 5.15 nmollOO ml glomerular filtration rate (normal < 1.92), serum 25(0W) vitamin D was 9 nmoMl (normal 18-128) and serum 1,25(OH)2D was 69 pmolIl (normal 46-207) . Other biochemical parameters including serum creatinine, serum aldolase, serum creatinine kinase and plasma insulin were within normal limits. Forearm mineral content measured by single photon absorptiometry was normal.
At operation (Dr L Delbridge), four enlarged parathyroids were found. The left upper gland weighed 3.9 g and contained a large oxyphilic nodule. The two lower glands were also removed. These weighed 0.10 and 0.129 g, respectively, and histological examination was interpreted as showing hyperplastic changes. The fourth gland was thought to be only slightly enlarged and was left in the neck.
Postoperative recovery was unremarkable with consistently normal serum calcium and serum PTH concentrations. After the operation the patient reported subjective improvement in her muscle strength, although there have been no objective changes on muscle testing.
Discussion
Myotonic dystrophy is an autosomal dominant disorder with characteristic changes ofmuscle weakness, myotonia, cataracts and frontal balding2. Endocrine disturbance associated with this disease include insulin resistance3, abnormal thyrotrophic hormone responses to thryotrophin-releasing hormone4 and a reduction in adrenal androgens5. However, while there is a well known association between muscle weakness and hyperparathyroidism5, we know of no association between myotonic dystrophy and hyperparathyroidism. In a group of265 patients with primary hyperparathyroidism previously reported from this unit7 there were no cases of myotonic dystrophy. Moreover, a study of 23 patients with myotonic dystrophy8 found normal serum calcium in all of them and normal serum immunoreactive parathyroid hormone values in all but one in whom there was a marginal elevation.
While a single case may obviously be due to a chance association, the co-existence ofthese two disorders may throw further light on the intriguing endocrine abnormalities seen in myotonic dystrophy. 
